Clinical Trial Update: Efficacy and Tolerability of Treatment With Lanthanum Carbonate in Patients With End Stage Renal Disease Receiving Dialysis [Phase 3]

View source ↗

Summary

Phase 3 trial update evaluating efficacy and tolerability of lanthanum carbonate in end stage renal disease patients on dialysis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Kidney Disease
• End-stage Renal Disease

Drugs mentioned

• LANTHANUM CARBONATE (lanthanum carbonate)

Snippet

Sponsor: Shire | Conditions: Kidney Failure, Chronic | Phase 3 | Status: COMPLETED